Key result
Human-induced pluripotent stem cell-derived cardiomyocyte models provide novel insights into the pathophysiological mechanisms of Brugada syndrome and offer opportunities for personalized medicine.
Why the study?
This review aimed to compare different models of Brugada syndrome to better understand the roles of human-induced pluripotent stem cell-derived cardiomyocytes in research and future personalized medicine.
Comparison
Different experimental models of Brugada syndrome
Design
Review
Loading...
Supports stem cell models for Brugada syndrome research; leaves open clinical translation pending validation.
Human-induced pluripotent stem cell-derived cardiomyocytes represent a promising experimental model for advancing the understanding and personalized treatment of Brugada syndrome.
A 2022 study conducted a review in Brugada syndrome. Human-induced pluripotent stem cell-derived cardiomyocytes vs. Animal models and heterologous expression systems was evaluated. Human-induced pluripotent stem cell-derived cardiomyocyte models provide novel insights into the pathophysiological mechanisms of Brugada syndrome and offer opportunities for personalized medicine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: